Economic burden of cardiovascular diseases in the enlarged European Union.

By J. Leal, R. Luengo-Fernandez, A. Gray, S. Petersen, M. Rayner. European Heart Journal, 2006

752 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. (2007, neutral): “The estimated total cost of CVDs in the EU countries was E168 757 million in 2003.(8) CVD mortality rates vary with age, gender, socio-economic status, ethnicity, and geographical region.”
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit (2007, neutral): “The estimated total cost of CVDs in the EU countries was E168 757 million in 2003.(8) CVD mortality rates vary with age, gender, socio-economic status, ethnicity, and geographical region.”
Osteoporosis in the European Union: medical management, epidemiology and economic burden (2013, background): “This has been explored for the use of alendronate [107, 116] risedronate [114], denosumab [113], raloxifene [117] and strontium ranelate [111].”